Animal, in vitro and computational models for preclinical analysis of cell-based cancer therapies

Dr Peter Simpson, Chief Scientific Officer for Medicines Discovery Catapult will be speaking at the event.

The NC3Rs and the Cell and Gene Therapy Catapult are hosting a one day workshop to explore preclinical testing of cell-based therapies for cancer.

The workshop will focus on:

  • The current best practice in developing cell-based therapies.
  • The benefits and limitations of using animal and non-animal models.
  • How translation can be enabled by the application of in vitro and computational methods.
  • Funding opportunities in preclinical modelling of cell-based therapies.

For more information and to register please see their website.